‘Adipaging’: ageing and obesity share biological hallmarks related to a dysfunctional adipose tissue

Journal of Physiology

Volumn 594, Issue 12, 2016, Pages 3187-3207

  Pérez, Laura M ^a   Pareja Galeano, Helios ^b,c   Sanchis Gomar, Fabián ^c   Emanuele, Enzo ^d   Lucia, Alejandro ^b,c   Gálvez, Beatriz G ^a,b  

^a CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

^b UNIVERSIDAD EUROPEA DE MADRID   (Spain)

^c Research Institute Hospital 12 de Octubre ^*  (Spain)

^d 2E Science ^*  (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINAMIDE ADENINE DINUCLEOTIDE; SIRTUIN 1;

ADIPOGENESIS; ADIPOSE DERIVED MESENCHYMAL STEM CELL; ADIPOSE TISSUE; AGING; ALZHEIMER DISEASE; BASAL METABOLIC RATE; BODY FAT; BODY MASS; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; DIABETES MELLITUS; DIFFUSE LEWY BODY DISEASE; DISEASE ASSOCIATION; DYSLIPIDEMIA; EPIGENETICS; FRONTOTEMPORAL DEMENTIA; HUMAN; HYDROCEPHALUS; HYPERTENSION; INFLAMMATION; INSULIN RESISTANCE; LIPID STORAGE; MESENCHYMAL STEM CELL; MILD COGNITIVE IMPAIRMENT; MULTIINFARCT DEMENTIA; NONHUMAN; OBESITY; OSTEOPOROSIS; PATHOPHYSIOLOGY; PHENOTYPE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

EID: 84974711017     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/JP271691     Document Type: Review

References (271)

1. Aguilera O, Fernandez AF, Munoz A & Fraga MF (2010). Epigenetics and environment: a complex relationship. J Appl Physiol (1985) 109, 243–251.
2. Aguirre L, Napoli N, Waters D, Qualls C, Villareal DT & Armamento-Villareal R (2014). Increasing adiposity is associated with higher adipokine levels and lower bone mineral density in obese older adults. J Clin Endocrinol Metab 99, 3290–3297.
3. Ahima RS (2009). Connecting obesity, aging and diabetes. Nat Med 15, 996–997.
4. Ahima RS, Saper CB, Flier JS & Elmquist JK (2000). Leptin regulation of neuroendocrine systems. Front Neuroendocrinol 21, 263–307.
5. Alves MD, Brites C & Sprinz E (2014). HIV-associated lipodystrophy: a review from a Brazilian perspective. Ther Clin Risk Manag 10, 559–566.
6. Anderson EK, Gutierrez DA & Hasty AH (2010). Adipose tissue recruitment of leukocytes. Curr Opin Lipidol 21, 172–177.
7. Arner P, Sinha I, Thorell A, Ryden M, Dahlman-Wright K & Dahlman I (2015). The epigenetic signature of subcutaneous fat cells is linked to altered expression of genes implicated in lipid metabolism in obese women. Clin Epigenetics 7, 93.
8. Arnoldussen IA, Kiliaan AJ & Gustafson DR (2014). Obesity and dementia: adipokines interact with the brain. Eur Neuropsychopharmacol 24, 1982–1999.
9. Autry AE & Monteggia LM (2012). Brain-derived neurotrophic factor and neuropsychiatric disorders. Pharmacol Rev 64, 238–258.
10. Banu J (2013). Causes, consequences, and treatment of osteoporosis in men. Drug Des Devel Ther 7, 849–860.
11. Baptista LS, Silva KR & Borojevic R (2015). Obesity and weight loss could alter the properties of adipose stem cells? World J Stem Cells 7, 165–173.
12. Barness LA, Opitz JM & Gilbert-Barness E (2007). Obesity: genetic, molecular, and environmental aspects. Am J Med Genet A 143A, 3016–3034.
13. Baron AD, Laakso M, Brechtel G, Hoit B, Watt C & Edelman SV (1990). Reduced postprandial skeletal muscle blood flow contributes to glucose intolerance in human obesity. J Clin Endocrinol Metab 70, 1525–1533.
14. Barzilai N & Bartke A (2009). Biological approaches to mechanistically understand the healthy life span extension achieved by calorie restriction and modulation of hormones. J Gerontol A Biol Sci Med Sci 64, 187–191.
15. Barzilai N & Gupta G (1999a). Interaction between aging and syndrome X: new insights on the pathophysiology of fat distribution. Ann N Y Acad Sci 892, 58–72.
16. Barzilai N & Gupta G (1999b). Revisiting the role of fat mass in the life extension induced by caloric restriction. J Gerontol A Biol Sci Med Sci 54, B89–B96; discussion B97–B98.
17. Barzilai N, Huffman DM, Muzumdar RH & Bartke A (2012). The critical role of metabolic pathways in aging. Diabetes 61, 1315–1322.
18. Basu R, Breda E, Oberg AL, Powell CC, Dalla Man C, Basu A, Vittone JL, Klee GG, Arora P, Jensen MD, Toffolo G, Cobelli C & Rizza RA (2003). Mechanisms of the age-associated deterioration in glucose tolerance: contribution of alterations in insulin secretion, action, and clearance. Diabetes 52, 1738–1748.
19. Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, Prabhu VV, Allard JS, Lopez-Lluch G, Lewis K, Pistell PJ, Poosala S, Becker KG, Boss O, Gwinn D, Wang M, Ramaswamy S, Fishbein KW, Spencer RG, Lakatta EG, Le Couteur D, Shaw RJ, Navas P, Puigserver P, Ingram DK, de Cabo R & Sinclair DA (2006). Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444, 337–342.
20. Beane OS, Fonseca VC, Cooper LL, Koren G & Darling EM (2014). Impact of aging on the regenerative properties of bone marrow-, muscle-, and adipose-derived mesenchymal stem/stromal cells. PLoS One 9, e115963.
21. Bell JA, Kivimaki M & Hamer M (2014). Metabolically healthy obesity and risk of incident type 2 diabetes: a meta-analysis of prospective cohort studies. Obes Rev 15, 504–515.
22. Berry DC, Stenesen D, Zeve D & Graff JM (2013). The developmental origins of adipose tissue. Development 140, 3939–3949.
23. Berryman DE, Christiansen JS, Johannsson G, Thorner MO & Kopchick JJ (2008). Role of the GH/IGF-1 axis in lifespan and healthspan: lessons from animal models. Growth Horm IGF Res 18, 455–471.
24. Bevilacqua M, Dominguez LJ & Barbagallo M (2009). Insulin resistance and the cardiometabolic syndrome in HIV infection. J Cardiometab Syndr 4, 40–43.
25. Bik W & Baranowska B (2009). Adiponectin – a predictor of higher mortality in cardiovascular disease or a factor contributing to longer life? Neuro Endocrinol Lett 30, 180–184.
26. Binder DK & Scharfman HE (2004). Brain-derived neurotrophic factor. Growth Factors 22, 123–131.
27. Bluher M, Kahn BB & Kahn CR (2003). Extended longevity in mice lacking the insulin receptor in adipose tissue. Science 299, 572–574.
28. Boskey AL & Coleman R (2010). Aging and bone. J Dent Res 89, 1333–1348.
29. Brown RE & Kuk JL (2015). Consequences of obesity and weight loss: a devil's advocate position. Obes Rev 16, 77–87.
30. Brunner EJ, Shipley MJ, Ahmadi-Abhari S, Tabak AG, McEniery CM, Wilkinson IB, Marmot MG, Singh-Manoux A & Kivimaki M (2015). Adiposity, obesity, and arterial aging: longitudinal study of aortic stiffness in the Whitehall II cohort. Hypertension 66, 294–300.
31. Bruunsgaard H & Pedersen BK (2003). Age-related inflammatory cytokines and disease. Immunol Allergy Clin North Am 23, 15–39.
32. Burns A & Iliffe S (2009). Dementia. BMJ 338, b75.
33. Calori G, Lattuada G, Piemonti L, Garancini MP, Ragogna F, Villa M, Mannino S, Crosignani P, Bosi E, Luzi L, Ruotolo G & Perseghin G (2011). Prevalence, metabolic features, and prognosis of metabolically healthy obese Italian individuals: the Cremona Study. Diabetes Care 34, 210–215.
34. Camhi SM & Katzmarzyk PT (2014). Differences in body composition between metabolically healthy obese and metabolically abnormal obese adults. Int J Obes (Lond) 38, 1142–1145.
35. Canning KL, Brown RE, Jamnik VK & Kuk JL (2014). Relationship between obesity and obesity-related morbidities weakens with aging. J Gerontol A Biol Sci Med Sci 69, 87–92.
36. + metabolism and SIRT1 activity. Nature 458, 1056–1060.
37. Cao JJ (2011). Effects of obesity on bone metabolism. J Orthop Surg Res 6, 30.
38. Carr A, Samaras K, Burton S, Law M, Freund J, Chisholm DJ & Cooper DA (1998). A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. Aids 12, F51–F58.
39. Chakkalakal JV, Jones KM, Basson MA & Brack AS (2012). The aged niche disrupts muscle stem cell quiescence. Nature 490, 355–360.
40. Chalkiadaki A & Guarente L (2012). High-fat diet triggers inflammation-induced cleavage of SIRT1 in adipose tissue to promote metabolic dysfunction. Cell Metab 16, 180–188.
41. Chang GR, Chiu YS, Wu YY, Chen WY, Liao JW, Chao TH & Mao FC (2009). Rapamycin protects against high fat diet-induced obesity in C57BL/6 J mice. J Pharmacol Sci 109, 496–503.
42. Chang HC & Guarente L (2013). SIRT1 mediates central circadian control in the SCN by a mechanism that decays with aging. Cell 153, 1448–1460.
43. Chang Y, Kim BK, Yun KE, Cho J, Zhang Y, Rampal S, Zhao D, Jung HS, Choi Y, Ahn J, Lima JA, Shin H, Guallar E & Ryu S (2014). Metabolically-healthy obesity and coronary artery calcification. J Am Coll Cardiol 63, 2679–2686.
44. Chau YY, Bandiera R, Serrels A, Martinez-Estrada OM, Qing W, Lee M, Slight J, Thornburn A, Berry R, McHaffie S, Stimson RH, Walker BR, Chapuli RM, Schedl A & Hastie N (2014). Visceral and subcutaneous fat have different origins and evidence supports a mesothelial source. Nat Cell Biol 16, 367–375.
45. Chen SC & Tseng CH (2013). Dyslipidemia, kidney disease, and cardiovascular disease in diabetic patients. Rev Diabet Stud 10, 88–100.
46. Cheung AM & Giangregorio L (2012). Mechanical stimuli and bone health: what is the evidence? Curr Opin Rheumatol 24, 561–566.
47. Chung HY, Cesari M, Anton S, Marzetti E, Giovannini S, Seo AY, Carter C, Yu BP & Leeuwenburgh C (2009). Molecular inflammation: underpinnings of aging and age-related diseases. Ageing Res Rev 8, 18–30.
48. Colaianni G, Brunetti G, Faienza MF, Colucci S & Grano M (2014). Osteoporosis and obesity: Role of Wnt pathway in human and murine models. World J Orthop 5, 242–246.
49. Compston J (2015). Obesity and fractures in postmenopausal women. Curr Opin Rheumatol 27, 414–419.
50. Confavreux CB, Levine RL & Karsenty G (2009). A paradigm of integrative physiology, the crosstalk between bone and energy metabolisms. Mol Cell Endocrinol 310, 21–29.
51. Craft S & Watson GS (2004). Insulin and neurodegenerative disease: shared and specific mechanisms. Lancet Neurol 3, 169–178.
52. Cunha C, Brambilla R & Thomas KL (2010). A simple role for BDNF in learning and memory? Front Mol Neurosci 3, 1.
53. Dalzill C, Nigam A, Juneau M, Guilbeault V, Latour E, Mauriege P & Gayda M (2014). Intensive lifestyle intervention improves cardiometabolic and exercise parameters in metabolically healthy obese and metabolically unhealthy obese individuals. Can J Cardiol 30, 434–440.
54. Das M, Gabriely I & Barzilai N (2004). Caloric restriction, body fat and ageing in experimental models. Obes Rev 5, 13–19.
55. Deane R, Wu Z & Zlokovic BV (2004). RAGE (yin) versus LRP (yang) balance regulates alzheimer amyloid beta-peptide clearance through transport across the blood-brain barrier. Stroke 35, 2628–2631.
56. Denies MS, Johnson J, Maliphol AB, Bruno M, Kim A, Rizvi A, Rustici K & Medler S (2014). Diet-induced obesity alters skeletal muscle fiber types of male but not female mice. Physiol Rep 2, e00204.
57. De Toni F, Poglio S, Youcef AB, Cousin B, Pflumio F, Bourin P, Casteilla L & Laharrague P (2011). Human adipose-derived stromal cells efficiently support hematopoiesis in vitro and in vivo: a key step for therapeutic studies. Stem Cells Dev 20, 2127–2138.
58. Ding W, Cheung WW & Mak RH (2015). Impact of obesity on kidney function and blood pressure in children. World J Nephrol 4, 223–229.
59. Donato AJ, Henson GD, Hart CR, Layec G, Trinity JD, Bramwell RC, Enz RA, Morgan RG, Reihl KD, Hazra S, Walker AE, Richardson RS & Lesniewski LA (2014). The impact of ageing on adipose structure, function and vasculature in the B6D2F1 mouse: evidence of significant multisystem dysfunction. J Physiol 592, 4083–4096.
60. Dorner TE & Rieder A (2012). Obesity paradox in elderly patients with cardiovascular diseases. Int J Cardiol 155, 56–65.
61. Drogan D, Boeing H, Janke J, Schmitt B, Zhou Y, Walter J, Pischon T & Tierling S (2015). Regional distribution of body fat in relation to DNA methylation within the LPL, ADIPOQ and PPARgamma promoters in subcutaneous adipose tissue. Nutr Diabetes 5, e168.
62. Elgazar-Carmon V, Rudich A, Hadad N & Levy R (2008). Neutrophils transiently infiltrate intra-abdominal fat early in the course of high-fat feeding. J Lipid Res 49, 1894–1903.
63. Emmerzaal TL, Kiliaan AJ & Gustafson DR (2015). 2003–2013: a decade of body mass index, Alzheimer's disease, and dementia. J Alzheimers Dis 43, 739–755.
64. Enzi G, Gasparo M, Biondetti PR, Fiore D, Semisa M & Zurlo F (1986). Subcutaneous and visceral fat distribution according to sex, age, and overweight, evaluated by computed tomography. Am J Clin Nutr 44, 739–746.
65. Eto H, Ishimine H, Kinoshita K, Watanabe-Susaki K, Kato H, Doi K, Kuno S, Kurisaki A & Yoshimura K (2013). Characterization of human adipose tissue-resident hematopoietic cell populations reveals a novel macrophage subpopulation with CD34 expression and mesenchymal multipotency. Stem Cells Dev 22, 985–997.
66. Fewlass DC, Noboa K, Pi-Sunyer FX, Johnston JM, Yan SD & Tezapsidis N (2004). Obesity-related leptin regulates Alzheimer's Aβ. FASEB J 18, 1870–1878.
67. Finkelstein JL, Gala P, Rochford R, Glesby MJ & Mehta S (2015). HIV/AIDS and lipodystrophy: implications for clinical management in resource-limited settings. J Int AIDS Soc 18, 19033.
68. Fitzpatrick AL, Kuller LH, Lopez OL, Diehr P, O'Meara ES, Longstreth WT Jr & Luchsinger JA (2009). Midlife and late-life obesity and the risk of dementia: cardiovascular health study. Arch Neurol 66, 336–342.
69. Fiuza-Luces C, Garatachea N, Berger NA & Lucia A (2013). Exercise is the real polypill. Physiology (Bethesda) 28, 330–358.
70. Flegal KM, Carroll MD, Ogden CL & Johnson CL (2002). Prevalence and trends in obesity among US adults, 1999–2000. JAMA 288, 1723–1727.
71. Flores I, Cayuela ML & Blasco MA (2005). Effects of telomerase and telomere length on epidermal stem cell behavior. Science 309, 1253–1256.
72. Fraga MF & Esteller M (2007). Epigenetics and aging: the targets and the marks. Trends Genet 23, 413–418.
73. Funahashi H, Yada T, Suzuki R & Shioda S (2003). Distribution, function, and properties of leptin receptors in the brain. Int Rev Cytol 224, 1–27.
74. Galic S, Oakhill JS & Steinberg GR (2010). Adipose tissue as an endocrine organ. Mol Cell Endocrinol 316, 129–139.
75. Garatachea N, Pareja-Galeano H, Sanchis-Gomar F, Santos-Lozano A, Fiuza-Luces C, Moran M, Emanuele E, Joyner MJ & Lucia A (2015). Exercise attenuates the major hallmarks of aging. Rejuvenation Res 18, 57–89.
76. Gerhard GS, Styer AM, Strodel WE, Roesch SL, Yavorek A, Carey DJ, Wood GC, Petrick AT, Gabrielsen J, Ibele A, Benotti P, Rolston DD, Still CD & Argyropoulos G (2014). Gene expression profiling in subcutaneous, visceral and epigastric adipose tissues of patients with extreme obesity. Int J Obes (Lond) 38, 371–378.
77. Ghigliotti G, Barisione C, Garibaldi S, Fabbi P, Brunelli C, Spallarossa P, Altieri P, Rosa G, Spinella G, Palombo D, Arsenescu R & Arsenescu V (2014). Adipose tissue immune response: novel triggers and consequences for chronic inflammatory conditions. Inflammation 37, 1337–1353.
78. Gillum MP, Kotas ME, Erion DM, Kursawe R, Chatterjee P, Nead KT, Muise ES, Hsiao JJ, Frederick DW, Yonemitsu S, Banks AS, Qiang L, Bhanot S, Olefsky JM, Sears DD, Caprio S & Shulman GI (2011). SirT1 regulates adipose tissue inflammation. Diabetes 60, 3235–3245.
79. Gray J, Yeo GS, Cox JJ, Morton J, Adlam AL, Keogh JM, Yanovski JA, El Gharbawy A, Han JC, Tung YC, Hodges JR, Raymond FL, O'Rahilly S & Farooqi IS (2006). Hyperphagia, severe obesity, impaired cognitive function, and hyperactivity associated with functional loss of one copy of the brain-derived neurotrophic factor (BDNF) gene. Diabetes 55, 3366–3371.
80. Gregor MF & Hotamisligil GS (2007). Thematic review series: Adipocyte Biology. Adipocyte stress: the endoplasmic reticulum and metabolic disease. J Lipid Res 48, 1905–1914.
81. Gruver AL, Hudson LL & Sempowski GD (2007). Immunosenescence of ageing. J Pathol 211, 144–156.
82. Gu P & Xu A (2013). Interplay between adipose tissue and blood vessels in obesity and vascular dysfunction. Rev Endocr Metab Disord 14, 49–58.
83. Gulcelik NE, Halil M, Ariogul S & Usman A (2013). Adipocytokines and aging: adiponectin and leptin. Minerva Endocrinol 38, 203–210.
84. Gustafson D, Rothenberg E, Blennow K, Steen B & Skoog I (2003). An 18-year follow-up of overweight and risk of Alzheimer disease. Arch Intern Med 163, 1524–1528.
85. Gustafson DR (2010). Adiposity hormones and dementia. J Neurol Sci 299, 30–34.
86. Gustafson DR, Backman K, Waern M, Ostling S, Guo X, Zandi P, Mielke MM, Bengtsson C & Skoog I (2009). Adiposity indicators and dementia over 32 years in Sweden. Neurology 73, 1559–1566.
87. Hainer V & Aldhoon-Hainerova I (2013). Obesity paradox does exist. Diabetes Care 36 Suppl 2, S276–S281.
88. Hall JE, do Carmo JM, da Silva AA, Wang Z & Hall ME (2015). Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms. Circ Res 116, 991–1006.
89. Hamer M & Stamatakis E (2012). Metabolically healthy obesity and risk of all-cause and cardiovascular disease mortality. J Clin Endocrinol Metab 97, 2482–2488.
90. Han S & Brunet A (2012). Histone methylation makes its mark on longevity. Trends Cell Biol 22, 42–49.
91. Harrison DE, Strong R, Sharp ZD, Nelson JF, Astle CM, Flurkey K, Nadon NL, Wilkinson JE, Frenkel K, Carter CS, Pahor M, Javors MA, Fernandez E & Miller RA (2009). Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 460, 392–395.
92. Harvey J (2003). Novel actions of leptin in the hippocampus. Ann Med 35, 197–206.
93. Hayden KM, Zandi PP, Lyketsos CG, Khachaturian AS, Bastian LA, Charoonruk G, Tschanz JT, Norton MC, Pieper CF, Munger RG, Breitner JC & Welsh-Bohmer KA (2006). Vascular risk factors for incident Alzheimer disease and vascular dementia: the Cache County study. Alzheimer Dis Assoc Disord 20, 93–100.
94. Hayes L, Pearce MS, Firbank MJ, Walker M, Taylor R & Unwin NC (2010). Do obese but metabolically normal women differ in intra-abdominal fat and physical activity levels from those with the expected metabolic abnormalities? A cross-sectional study. BMC Public Health 10, 723.
95. Hinnouho GM, Czernichow S, Dugravot A, Nabi H, Brunner EJ, Kivimaki M & Singh-Manoux A (2015). Metabolically healthy obesity and the risk of cardiovascular disease and type 2 diabetes: the Whitehall II cohort study. Eur Heart J 36, 551–559.
96. Hinton RB & Yutzey KE (2011). Heart valve structure and function in development and disease. Annu Rev Physiol 73, 29–46.
97. Hirtz D, Thurman DJ, Gwinn-Hardy K, Mohamed M, Chaudhuri AR & Zalutsky R (2007). How common are the “common” neurologic disorders? Neurology 68, 326–337.
98. Holliday R & Pugh JE (1975). DNA modification mechanisms and gene activity during development. Science 187, 226–232.
99. Holloszy JO (2013). “Deficiency” of mitochondria in muscle does not cause insulin resistance. Diabetes 62, 1036–1040.
100. Holsinger RM, Schnarr J, Henry P, Castelo VT & Fahnestock M (2000). Quantitation of BDNF mRNA in human parietal cortex by competitive reverse transcription-polymerase chain reaction: decreased levels in Alzheimer's disease. Brain Res Mol Brain Res 76, 347–354.
101. Horvath S, Erhart W, Brosch M, Ammerpohl O, von Schonfels W, Ahrens M, Heits N, Bell JT, Tsai PC, Spector TD, Deloukas P, Siebert R, Sipos B, Becker T, Rocken C, Schafmayer C & Hampe J (2014). Obesity accelerates epigenetic aging of human liver. Proc Natl Acad Sci USA 111, 15538–15543.
102. Hotamisligil GS, Shargill NS & Spiegelman BM (1993). Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259, 87–91.
103. Hu FB, Willett WC, Li T, Stampfer MJ, Colditz GA & Manson JE (2004). Adiposity as compared with physical activity in predicting mortality among women. N Engl J Med 351, 2694–2703.
104. Huffman K (2012). The developing, aging neocortex: how genetics and epigenetics influence early developmental patterning and age-related change. Front Genet 3, 212.
105. Ilich JZ, Kelly OJ, Inglis JE, Panton LB, Duque G & Ormsbee MJ (2014). Interrelationship among muscle, fat, and bone: connecting the dots on cellular, hormonal, and whole body levels. Ageing Res Rev 15, 51–60.
106. Jagust W, Harvey D, Mungas D & Haan M (2005). Central obesity and the aging brain. Arch Neurol 62, 1545–1548.
107. Janiszewski PM & Ross R (2010). Effects of weight loss among metabolically healthy obese men and women. Diabetes Care 33, 1957–1959.
108. Janzen V, Forkert R, Fleming HE, Saito Y, Waring MT, Dombkowski DM, Cheng T, DePinho RA, Sharpless NE & Scadden DT (2006). Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a. Nature 443, 421–426.
109. Jheng HF, Huang SH, Kuo HM, Hughes MW & Tsai YS (2015). Molecular insight and pharmacological approaches targeting mitochondrial dynamics in skeletal muscle during obesity. Ann N Y Acad Sci 1350, 82–94.
110. Jia G, Aroor AR, DeMarco VG, Martinez-Lemus LA, Meininger GA & Sowers JR (2015). Vascular stiffness in insulin resistance and obesity. Front Physiol 6, 231.
111. Johannsen DL, Conley KE, Bajpeyi S, Punyanitya M, Gallagher D, Zhang Z, Covington J, Smith SR & Ravussin E (2012). Ectopic lipid accumulation and reduced glucose tolerance in elderly adults are accompanied by altered skeletal muscle mitochondrial activity. J Clin Endocrinol Metab 97, 242–250.
112. Jurk D, Wilson C, Passos JF, Oakley F, Correia-Melo C, Greaves L, Saretzki G, Fox C, Lawless C, Anderson R, Hewitt G, Pender SLF, Fullard N, Nelson G, Mann J, van de Sluis B, Mann DA & von Zglinicki T (2014). Chronic inflammation induces telomere dysfunction and accelerates ageing in mice. Nat Commun 2, 4172.
113. Kalaria RN (2010). Vascular basis for brain degeneration: faltering controls and risk factors for dementia. Nutr Rev 68 Suppl 2, S74–S87.
114. Kantartzis K, Machann J, Schick F, Rittig K, Machicao F, Fritsche A, Haring HU & Stefan N (2011). Effects of a lifestyle intervention in metabolically benign and malign obesity. Diabetologia 54, 864–868.
115. Karelis AD (2008). Metabolically healthy but obese individuals. Lancet 372, 1281–1283.
116. Karelis AD, Messier V, Brochu M & Rabasa-Lhoret R (2008). Metabolically healthy but obese women: effect of an energy-restricted diet. Diabetologia 51, 1752–1754.
117. Kernie SG, Liebl DJ & Parada LF (2000). BDNF regulates eating behavior and locomotor activity in mice. EMBO J 19, 1290–1300.
118. Kershaw EE & Flier JS (2004). Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89, 2548–2556.
119. Kiliaan AJ, Arnoldussen IA & Gustafson DR (2014). Adipokines: a link between obesity and dementia? Lancet Neurol 13, 913–923.
120. Kivipelto M, Helkala EL, Laakso MP, Hanninen T, Hallikainen M, Alhainen K, Soininen H, Tuomilehto J & Nissinen A (2001). Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. BMJ 322, 1447–1451.
121. Kivipelto M, Ngandu T, Fratiglioni L, Viitanen M, Kareholt I, Winblad B, Helkala EL, Tuomilehto J, Soininen H & Nissinen A (2005). Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. Arch Neurol 62, 1556–1560.
122. Klein JP & Waxman SG (2003). The brain in diabetes: molecular changes in neurons and their implications for end-organ damage. Lancet Neurol 2, 548–554.
123. Kohrt WM & Holloszy JO (1995). Loss of skeletal muscle mass with aging: effect on glucose tolerance. J Gerontol A Biol Sci Med Sci 50 Spec No, 68–72.
124. Komulainen P, Pedersen M, Hanninen T, Bruunsgaard H, Lakka TA, Kivipelto M, Hassinen M, Rauramaa TH, Pedersen BK & Rauramaa R (2008). BDNF is a novel marker of cognitive function in ageing women: the DR's EXTRA Study. Neurobiol Learn Mem 90, 596–603.
125. Kotas ME, Gorecki MC & Gillum MP (2013). Sirtuin-1 is a nutrient-dependent modulator of inflammation. Adipocyte 2, 113–118.
126. Krabbe KS, Nielsen AR, Krogh-Madsen R, Plomgaard P, Rasmussen P, Erikstrup C, Fischer CP, Lindegaard B, Petersen AM, Taudorf S, Secher NH, Pilegaard H, Bruunsgaard H & Pedersen BK (2007). Brain-derived neurotrophic factor (BDNF) and type 2 diabetes. Diabetologia 50, 431–438.
127. Kramer CK, Zinman B & Retnakaran R (2013). Are metabolically healthy overweight and obesity benign conditions?: A systematic review and meta-analysis. Ann Intern Med 159, 758–769.
128. Kritchevsky SB, Beavers KM, Miller ME, Shea MK, Houston DK, Kitzman DW & Nicklas BJ (2015). Intentional weight loss and all-cause mortality: a meta-analysis of randomized clinical trials. PLoS One 10, e0121993.
129. Kuk JL & Ardern CI (2009a). Are metabolically normal but obese individuals at lower risk for all-cause mortality? Diabetes Care 32, 2297–2299.
130. Kuk JL & Ardern CI (2009b). Influence of age on the association between various measures of obesity and all-cause mortality. J Am Geriatr Soc 57, 2077–2084.
131. Kuk JL, Ardern CI, Church TS, Sharma AM, Padwal R, Sui X & Blair SN (2011). Edmonton Obesity Staging System: association with weight history and mortality risk. Appl Physiol Nutr Metab 36, 570–576.
132. Lamas O, Martinez JA & Marti A (2004). Energy restriction restores the impaired immune response in overweight (cafeteria) rats. J Nutr Biochem 15, 418–425.
133. Lasselin J, Magne E, Beau C, Ledaguenel P, Dexpert S, Aubert A, Laye S & Capuron L (2014). Adipose inflammation in obesity: relationship with circulating levels of inflammatory markers and association with surgery-induced weight loss. J Clin Endocrinol Metab 99, E53–E61.
134. Lastra G & Manrique C (2015). Perivascular adipose tissue, inflammation and insulin resistance: link to vascular dysfunction and cardiovascular disease. Horm Mol Biol Clin Investig 22, 19–26.
135. Lee HC & Wei YH (2007). Oxidative stress, mitochondrial DNA mutation, and apoptosis in aging. Exp Biol Med (Maywood) 232, 592–606.
136. Leibson CL, Rocca WA, Hanson VA, Cha R, Kokmen E, O'Brien PC & Palumbo PJ (1997). The risk of dementia among persons with diabetes mellitus: a population-based cohort study. Ann N Y Acad Sci 826, 422–427.
137. Letra L, Santana I & Seica R (2014). Obesity as a risk factor for Alzheimer's disease: the role of adipocytokines. Metab Brain Dis 29, 563–568.
138. Li X, Ominsky MS, Niu QT, Sun N, Daugherty B, D'Agostin D, Kurahara C, Gao Y, Cao J, Gong J, Asuncion F, Barrero M, Warmington K, Dwyer D, Stolina M, Morony S, Sarosi I, Kostenuik PJ, Lacey DL, Simonet WS, Ke HZ & Paszty C (2008). Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength. J Bone Miner Res 23, 860–869.
139. Li Y, Daniel M & Tollefsbol TO (2011). Epigenetic regulation of caloric restriction in aging. BMC Med 9, 98.
140. Liesa M & Shirihai OS (2013). Mitochondrial dynamics in the regulation of nutrient utilization and energy expenditure. Cell Metab 17, 491–506.
141. Lind L & Lithell H (1993). Decreased peripheral blood flow in the pathogenesis of the metabolic syndrome comprising hypertension, hyperlipidemia, and hyperinsulinemia. Am Heart J 125, 1494–1497.
142. Ling C & Ronn T (2014). Epigenetic adaptation to regular exercise in humans. Drug Discov Today 19, 1015–1018.
143. Lisko I, Tiainen K, Stenholm S, Luukkaala T, Hurme M, Lehtimaki T, Hervonen A & Jylha M (2012). Inflammation, adiposity, and mortality in the oldest old. Rejuvenation Res 15, 445–452.
144. Lolmede K, Duffaut C, Zakaroff-Girard A & Bouloumie A (2011). Immune cells in adipose tissue: key players in metabolic disorders. Diabetes Metab 37, 283–290.
145. Lombardi G, Perego S, Luzi L & Banfi G (2015). A four-season molecule: osteocalcin. Updates in its physiological roles. Endocrine 48, 394–404.
146. Lombardi G, Sanchis-Gomar F, Perego S, Sansoni V & Banfi B (2016). Implications of exercise-induced adipo-myokines in bone metabolism. Endocrine Doi: 10.1007/s12020-015-0834-0.
147. Lopez-Otin C, Blasco MA, Partridge L, Serrano M & Kroemer G (2013). The hallmarks of aging. Cell 153, 1194–1217.
148. Luchsinger JA, Tang MX, Stern Y, Shea S & Mayeux R (2001). Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort. Am J Epidemiol 154, 635–641.
149. Lumeng CN, Bodzin JL & Saltiel AR (2007). Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 117, 175–184.
150. Lyons WE, Mamounas LA, Ricaurte GA, Coppola V, Reid SW, Bora SH, Wihler C, Koliatsos VE & Tessarollo L (1999). Brain-derived neurotrophic factor-deficient mice develop aggressiveness and hyperphagia in conjunction with brain serotonergic abnormalities. Proc Natl Acad Sci USA 96, 15239–15244.
151. Ma X, Lee P, Chisholm DJ & James DE (2015). Control of adipocyte differentiation in different fat depots; implications for pathophysiology or therapy. Front Endocrinol 6, 1.
152. Mantzoros CS, Moschos S, Avramopoulos I, Kaklamani V, Liolios A, Doulgerakis DE, Griveas I, Katsilambros N & Flier JS (1997). Leptin concentrations in relation to body mass index and the tumor necrosis factor-alpha system in humans. J Clin Endocrinol Metab 82, 3408–3413.
153. Martin SL, Hardy TM & Tollefsbol TO (2013). Medicinal chemistry of the epigenetic diet and caloric restriction. Curr Med Chem 20, 4050–4059.
154. Masoro EJ (2006). Caloric restriction and aging: controversial issues. J Gerontol A Biol Sci Med Sci 61, 14–19.
155. Matarese G, Moschos S & Mantzoros CS (2005). Leptin in immunology. J Immunol 174, 3137–3142.
156. Mathieu P, Lemieux I & Despres JP (2010). Obesity, inflammation, and cardiovascular risk. Clin Pharmacol Ther 87, 407–416.
157. Mauer J, Chaurasia B, Goldau J, Vogt MC, Ruud J, Nguyen KD, Theurich S, Hausen AC, Schmitz J, Bronneke HS, Estevez E, Allen TL, Mesaros A, Partridge L, Febbraio MA, Chawla A, Wunderlich FT & Bruning JC (2014). Signaling by IL-6 promotes alternative activation of macrophages to limit endotoxemia and obesity-associated resistance to insulin. Nat Immunol 15, 423–430.
158. Maurer MS (2015). Noninvasive identification of ATTRwt cardiac amyloid: the re-emergence of nuclear cardiology. Am J Med 128, 1275–1280.
159. McLachlan M & Wasserman P (1981). Changes in sizes and distensibility of the aging kidney. Br J Radiol 54, 488–491.
160. Miao CY & Li ZY (2012). The role of perivascular adipose tissue in vascular smooth muscle cell growth. Br J Pharmacol 165, 643–658.
161. Migliaccio S, Greco EA, Wannenes F, Donini LM & Lenzi A (2014). Adipose, bone and muscle tissues as new endocrine organs: role of reciprocal regulation for osteoporosis and obesity development. Horm Mol Biol Clin Investig 17, 39–51.
162. Minamino T & Komuro I (2007). Vascular cell senescence: contribution to atherosclerosis. Circ Res 100, 15–26.
163. Minamino T & Komuro I (2008). Vascular aging: insights from studies on cellular senescence, stem cell aging, and progeroid syndromes. Nat Clin Pract Cardiovasc Med 5, 637–648.
164. Minamino T, Orimo M, Shimizu I, Kunieda T, Yokoyama M, Ito T, Nojima A, Nabetani A, Oike Y, Matsubara H, Ishikawa F & Komuro I (2009). A crucial role for adipose tissue p53 in the regulation of insulin resistance. Nat Med 15, 1082–1087.
165. Minor RK, Baur JA, Gomes AP, Ward TM, Csiszar A, Mercken EM, Abdelmohsen K, Shin YK, Canto C, Scheibye-Knudsen M, Krawczyk M, Irusta PM, Martin-Montalvo A, Hubbard BP, Zhang Y, Lehrmann E, White AA, Price NL, Swindell WR, Pearson KJ, Becker KG, Bohr VA, Gorospe M, Egan JM, Talan MI, Auwerx J, Westphal CH, Ellis JL, Ungvari Z, Vlasuk GP, Elliott PJ, Sinclair DA & de Cabo R (2011). SRT1720 improves survival and healthspan of obese mice. Sci Rep 1, 70.
166. Mitchell SJ, Martin-Montalvo A, Mercken EM, Palacios HH, Ward TM, Abulwerdi G, Minor RK, Vlasuk GP, Ellis JL, Sinclair DA, Dawson J, Allison DB, Zhang Y, Becker KG, Bernier M & de Cabo R (2014). The SIRT1 activator SRT1720 extends lifespan and improves health of mice fed a standard diet. Cell Rep 6, 836–843.
167. Monteiro R & Azevedo I (2010). Chronic inflammation in obesity and the metabolic syndrome. Mediators Inflamm 2010, 289645.
168. Mori K (2000). Tripartite management of unfolded proteins in the endoplasmic reticulum. Cell 101, 451–454.
169. Morkedal B, Vatten LJ, Romundstad PR, Laugsand LE & Janszky I (2014). Risk of myocardial infarction and heart failure among metabolically healthy but obese individuals: HUNT (Nord-Trondelag Health Study), Norway. J Am Coll Cardiol 63, 1071–1078.
170. Morley JE, Baumgartner RN, Roubenoff R, Mayer J & Nair KS (2001). Sarcopenia. J Lab Clin Med 137, 231–243.
171. Muzumdar R, Allison DB, Huffman DM, Ma X, Atzmon G, Einstein FH, Fishman S, Poduval AD, McVei T, Keith SW & Barzilai N (2008). Visceral adipose tissue modulates mammalian longevity. Aging Cell 7, 438–440.
172. Nava-Gonzalez EJ, Gallegos-Cabriales EC & Bastarrachea RA (2014). [Phenotypes of bone and adipose tissue metabolism. A systematic review of their relationship]. Revista medica del Instituto Mexicano del Seguro Social 52, 644–650.
173. North BJ & Sinclair DA (2012). The intersection between aging and cardiovascular disease. Circ Res 110, 1097–1108.
174. Ogorodnikova AD, Kim M, McGinn AP, Muntner P, Khan U & Wildman RP (2012). Incident cardiovascular disease events in metabolically benign obese individuals. Obesity (Silver Spring) 20, 651–659.
175. Oh J, Lee YD & Wagers AJ (2014). Stem cell aging: mechanisms, regulators and therapeutic opportunities. Nat Med 20, 870–880.
176. Olefsky JM & Glass CK (2010). Macrophages, inflammation, and insulin resistance. Annu Rev Physiol 72, 219–246.
177. Olivetti G, Melissari M, Capasso JM & Anversa P (1991). Cardiomyopathy of the aging human heart. Myocyte loss and reactive cellular hypertrophy. Circ Res 68, 1560–1568.
178. Onate B, Vilahur G, Camino-Lopez S, Diez-Caballero A, Ballesta-Lopez C, Ybarra J, Moscatiello F, Herrero J & Badimon L (2013). Stem cells isolated from adipose tissue of obese patients show changes in their transcriptomic profile that indicate loss in stemcellness and increased commitment to an adipocyte-like phenotype. BMC Genomics 14, 625.
179. Onate B, Vilahur G, Ferrer-Lorente R, Ybarra J, Diez-Caballero A, Ballesta-Lopez C, Moscatiello F, Herrero J & Badimon L (2012). The subcutaneous adipose tissue reservoir of functionally active stem cells is reduced in obese patients. FASEB J 26, 4327–4336.
180. Ormsbee MJ, Prado CM, Ilich JZ, Purcell S, Siervo M, Folsom A & Panton L (2014). Osteosarcopenic obesity: the role of bone, muscle, and fat on health. J Cachexia Sarcopenia Muscle 5, 183–192.
181. Ortega FB, Lee DC, Katzmarzyk PT, Ruiz JR, Sui X, Church TS & Blair SN (2013). The intriguing metabolically healthy but obese phenotype: cardiovascular prognosis and role of fitness. Eur Heart J 34, 389–397.
182. Ortega FJ, Moreno M, Mercader JM, Moreno-Navarrete JM, Fuentes-Batllevell N, Sabater M, Ricart W & Fernandez-Real JM (2015). Inflammation triggers specific microRNA profiles in human adipocytes and macrophages and in their supernatants. Clin Epigenetics 7, 49.
183. Ouchi N, Parker JL, Lugus JJ & Walsh K (2011). Adipokines in inflammation and metabolic disease. Nat Rev Immunol 11, 85–97.
184. Papathanassoglou ED, Moynihan JA, Ackerman MH & Mantzoros CS (2001). Serum leptin levels are higher but are not independently associated with severity or mortality in the multiple organ dysfunction/systemic inflammatory response syndrome: a matched case control and a longitudinal study. Clin Endocrinol (Oxf) 54, 225–233.
185. Pareja-Galeano H, Sanchis-Gomar F & Garcia-Gimenez JL (2014). Physical exercise and epigenetic modulation: elucidating intricate mechanisms. Sports Med 44, 429–436.
186. Park CR (2001). Cognitive effects of insulin in the central nervous system. Neurosci Biobehav Rev 25, 311–323.
187. Patel P & Abate N (2013). Body fat distribution and insulin resistance. Nutrients 5, 2019–2027.
188. Peng XR, Gennemark P, O'Mahony G & Bartesaghi S (2015). Unlock the thermogenic potential of adipose tissue: pharmacological modulation and implications for treatment of diabetes and obesity. Front Endocrinol 6, 174.
189. Perez LM, Bernal A, De Lucas B, San Martin N, Mastrangelo A, García A, Barbas C & Galvez BG (2015). Altered metabolic and stemness capacity of adipose tissue-derived stem cells from obese mouse and human. PLoS One 10, e123397.
190. Petersen RC (2011). Clinical practice. Mild cognitive impairment. N Engl J Med 364, 2227–2234.
191. Peterson CM, Johannsen DL & Ravussin E (2012). Skeletal muscle mitochondria and aging: a review. J Aging Res 2012, 194821.
192. Phillips HS, Hains JM, Armanini M, Laramee GR, Johnson SA & Winslow JW (1991). BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease. Neuron 7, 695–702.
193. Picard F, Kurtev M, Chung N, Topark-Ngarm A, Senawong T, Machado De Oliveira R, Leid M, McBurney MW & Guarente L (2004). Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma. Nature 429, 771–776.
194. Poelkens F, Eijsvogels TM, Brussee P, Verheggen RJ, Tack CJ & Hopman MT (2014). Physical fitness can partly explain the metabolically healthy obese phenotype in women. Exp Clin Endocrinol Diabetes 122, 87–91.
195. Poonpet T & Honsawek S (2014). Adipokines: Biomarkers for osteoarthritis? World J Orthop 5, 319–327.
196. Poulose N & Raju R (2015). Sirtuin regulation in aging and injury. Biochim Biophys Acta 1852, 2442–2455.
197. Qatanani M & Lazar MA (2007). Mechanisms of obesity-associated insulin resistance: many choices on the menu. Genes Dev 21, 1443–1455.
198. Qizilbash N, Gregson J, Johnson ME, Pearce N, Douglas I, Wing K, Evans SJ & Pocock SJ (2015). BMI and risk of dementia in two million people over two decades: a retrospective cohort study. Lancet Diabetes Endocrinol 3, 431–436.
199. Querfurth HW & LaFerla FM (2010). Alzheimer's disease. N Engl J Med 362, 329–344.
200. Razay G & Vreugdenhil A (2005). Obesity in middle age and future risk of dementia: midlife obesity increases risk of future dementia. BMJ 331, 455; author reply 455.
201. Rios M, Fan G, Fekete C, Kelly J, Bates B, Kuehn R, Lechan RM & Jaenisch R (2001). Conditional deletion of brain-derived neurotrophic factor in the postnatal brain leads to obesity and hyperactivity. Mol Endocrinol 15, 1748–1757.
202. Ristow M & Schmeisser S (2011). Extending life span by increasing oxidative stress. Free Radic Biol Med 51, 327–336.
203. Romacho T, Elsen M, Rohrborn D & Eckel J (2014). Adipose tissue and its role in organ crosstalk. Acta Physiol (Oxf) 210, 733–753.
204. Rosen CJ & Bouxsein ML (2006). Mechanisms of disease: is osteoporosis the obesity of bone? Nat Clin Pract Rheumatol 2, 35–43.
205. Rossi DJ, Jamieson CH & Weissman IL (2008). Stems cells and the pathways to aging and cancer. Cell 132, 681–696.
206. Saely CH, Geiger K & Drexel H (2012). Brown versus white adipose tissue: a mini-review. Gerontology 58, 15–23.
207. Salam N, Rane S, Das R, Faulkner M, Gund R, Kandpal U, Lewis V, Mattoo H, Prabhu S, Ranganathan V, Durdik J, George A, Rath S & Bal V (2013). T cell ageing: effects of age on development, survival & function. Indian J Med Res 138, 595–608.
208. Salminen A, Kaarniranta K & Kauppinen A (2012). Inflammaging: disturbed interplay between autophagy and inflammasomes. Aging (Albany NY) 4, 166–175.
209. Sanchis-Gomar F & Derbre F (2014). Mitochondrial fission and fusion in human diseases. N Engl J Med 370, 1073–1074.
210. Sanchis-Gomar F, Garcia-Gimenez JL, Gomez-Cabrera MC & Pallardo FV (2014). Mitochondrial biogenesis in health and disease. Molecular and therapeutic approaches. Curr Pharm Des 20, 5619–5633.
211. Sanchis-Gomar F, Lucia A, Yvert T, Ruiz-Casado A, Pareja-Galeano H, Santos-Lozano A, Fiuza-Luces C, Garatachea N, Lippi G, Bouchard C & Berger NA (2015). Physical inactivity and low fitness deserve more attention to alter cancer risk and prognosis. Cancer Prev Res (Phila) 8, 105–110.
212. Sano M, Minamino T, Toko H, Miyauchi H, Orimo M, Qin Y, Akazawa H, Tateno K, Kayama Y, Harada M, Shimizu I, Asahara T, Hamada H, Tomita S, Molkentin JD, Zou Y & Komuro I (2007). p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload. Nature 446, 444–448.
213. Sasaki T (2015). Age-associated weight gain, leptin, and SIRT1: A possible role for hypothalamic SIRT1 in the prevention of weight gain and aging through modulation of leptin sensitivity. Front Endocrinol 6, 109.
214. Schipper HS, Prakken B, Kalkhoven E & Boes M (2012). Adipose tissue-resident immune cells: key players in immunometabolism. Trends Endocrinol Metab 23, 407–415.
215. Schutz Y (2004). Concept of fat balance in human obesity revisited with particular reference to de novo lipogenesis. Int J Obes Relat Metab Disord 28 Suppl 4, S3–S11.
216. Schwab P & Scalapino K (2011). Exercise for bone health: rationale and prescription. Curr Opin Rheumatol 23, 137–141.
217. Schwer B & Verdin E (2008). Conserved metabolic regulatory functions of sirtuins. Cell Metab 7, 104–112.
218. Seals DR & Dinenno FA (2004). Collateral damage: cardiovascular consequences of chronic sympathetic activation with human aging. Am J Physiol Heart Circ Physiol 287, H1895–H1905.
219. Selman C, Lingard S, Choudhury AI, Batterham RL, Claret M, Clements M, Ramadani F, Okkenhaug K, Schuster E, Blanc E, Piper MD, Al-Qassab H, Speakman JR, Carmignac D, Robinson IC, Thornton JM, Gems D, Partridge L & Withers DJ (2008). Evidence for lifespan extension and delayed age-related biomarkers in insulin receptor substrate 1 null mice. FASEB J 22, 807–818.
220. Selman C, Tullet JM, Wieser D, Irvine E, Lingard SJ, Choudhury AI, Claret M, Al-Qassab H, Carmignac D, Ramadani F, Woods A, Robinson IC, Schuster E, Batterham RL, Kozma SC, Thomas G, Carling D, Okkenhaug K, Thornton JM, Partridge L, Gems D & Withers DJ (2009). Ribosomal protein S6 kinase 1 signaling regulates mammalian life span. Science 326, 140–144.
221. Sesti G, Folli F, Perego L, Hribal ML & Pontiroli AE (2011). Effects of weight loss in metabolically healthy obese subjects after laparoscopic adjustable gastric banding and hypocaloric diet. PLoS One 6, e17737.
222. Shapiro H, Lutaty A & Ariel A (2011). Macrophages, meta-inflammation, and immuno-metabolism. TheScientificWorldJournal 11, 2509–2529.
223. Sharpless NE & DePinho RA (2007). How stem cells age and why this makes us grow old. Nat Rev Mol Cell Biol 8, 703–713.
224. Shimizu I, Yoshida Y, Katsuno T, Tateno K, Okada S, Moriya J, Yokoyama M, Nojima A, Ito T, Zechner R, Komuro I, Kobayashi Y & Minamino T (2012). p53-induced adipose tissue inflammation is critically involved in the development of insulin resistance in heart failure. Cell Metab 15, 51–64.
225. Shimizu I, Yoshida Y & Minamino T (2015). Pathological role of adipose tissue dysfunction in cardio-metabolic disorders. Int Heart J 56, 255–259.
226. Shin MJ, Hyun YJ, Kim OY, Kim JY, Jang Y & Lee JH (2006). Weight loss effect on inflammation and LDL oxidation in metabolically healthy but obese (MHO) individuals: low inflammation and LDL oxidation in MHO women. Int J Obes (Lond) 30, 1529–1534.
227. Shoshani O & Zipori D (2015). Stress as a fundamental theme in cell plasticity. Biochim Biophys Acta 1849, 371–377.
228. Sohal RS & Orr WC (2012). The redox stress hypothesis of aging. Free Radic Biol Med 52, 539–555.
229. Sorensen TI, Rissanen A, Korkeila M & Kaprio J (2005). Intention to lose weight, weight changes, and 18-y mortality in overweight individuals without co-morbidities. PLoS Med 2, e171.
230. Srivastava T (2006). Nondiabetic consequences of obesity on kidney. Pediatr Nephrol 21, 463–470.
231. St-Onge MP (2005). Relationship between body composition changes and changes in physical function and metabolic risk factors in aging. Curr Opin Clin Nutr Metab Care 8, 523–528.
232. Stewart R, Masaki K, Xue QL, Peila R, Petrovitch H, White LR & Launer LJ (2005). A 32-year prospective study of change in body weight and incident dementia: the Honolulu-Asia Aging Study. Arch Neurol 62, 55–60.
233. Stranahan AM (2015). Models and mechanisms for hippocampal dysfunction in obesity and diabetes. Neuroscience 309, 125–139.
234. Stransky CA, Hsu VM, Dierov R, Hoover WJ, Donahue G, Bucky LP & Percec I (2012). Beyond fat grafting: what adipose tissue can teach us about the molecular mechanisms of human aging. Ann Plast Surg 69, 489–492.
235. Stuart CA, McCurry MP, Marino A, South MA, Howell ME, Layne AS, Ramsey MW & Stone MH (2013). Slow-twitch fiber proportion in skeletal muscle correlates with insulin responsiveness. J Clin Endocrinol Metab 98, 2027–2036.
236. Tanaka S, Isoda F, Ishihara Y, Kimura M & Yamakawa T (2001). T lymphopaenia in relation to body mass index and TNF-α in human obesity: adequate weight reduction can be corrective. Clin Endocrinol (Oxf) 54, 347–354.
237. Tchkonia T, Morbeck DE, Von Zglinicki T, Van Deursen J, Lustgarten J, Scrable H, Khosla S, Jensen MD & Kirkland JL (2010). Fat tissue, aging, and cellular senescence. Aging Cell 9, 667–684.
238. Tchkonia T, Thomou T, Zhu Y, Karagiannides I, Pothoulakis C, Jensen MD & Kirkland JL (2013). Mechanisms and metabolic implications of regional differences among fat depots. Cell Metab 17, 644–656.
239. Thompson RF, Atzmon G, Gheorghe C, Liang HQ, Lowes C, Greally JM & Barzilai N (2010). Tissue-specific dysregulation of DNA methylation in aging. Aging Cell 9, 506–518.
240. Thorp AA & Schlaich MP (2015). Relevance of sympathetic nervous system activation in obesity and metabolic syndrome. J Diabetes Res 2015, 341583.
241. Tilg H & Moschen AR (2006). Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 6, 772–783.
242. Tollervey JR & Lunyak VV (2011). Adult stem cells: simply a tool for regenerative medicine or an additional piece in the puzzle of human aging? Cell Cycle 10, 4173–4176.
243. Tollervey JR & Lunyak VV (2012). Epigenetics: judge, jury and executioner of stem cell fate. Epigenetics 7, 823–840.
244. Tzanetakou IP, Katsilambros NL, Benetos A, Mikhailidis DP & Perrea DN (2012). “Is obesity linked to aging?”: adipose tissue and the role of telomeres. Ageing Res Rev 11, 220–229.
245. Um SH, Frigerio F, Watanabe M, Picard F, Joaquin M, Sticker M, Fumagalli S, Allegrini PR, Kozma SC, Auwerx J & Thomas G (2004). Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity. Nature 431, 200–205.
246. Vaquero A, Scher M, Erdjument-Bromage H, Tempst P, Serrano L & Reinberg D (2007). SIRT1 regulates the histone methyl-transferase SUV39H1 during heterochromatin formation. Nature 450, 440–444.
247. Vaynman S & Gomez-Pinilla F (2006). Revenge of the “sit”: how lifestyle impacts neuronal and cognitive health through molecular systems that interface energy metabolism with neuronal plasticity. J Neurosci Res 84, 699–715.
248. Villareal DT, Apovian CM, Kushner RF, Klein S; American Society for Nutrition; NAASO, The Obesity Society (2005). Obesity in older adults: technical review and position statement of the American Society for Nutrition and NAASO, The Obesity Society. Obes Res 13, 1849–1863.
249. Ward MA, Carlsson CM, Trivedi MA, Sager MA & Johnson SC (2005). The effect of body mass index on global brain volume in middle-aged adults: a cross sectional study. BMC Neurol 5, 23.
250. Warolin J, Coenen KR, Kantor JL, Whitaker LE, Wang L, Acra SA, Roberts LJ 2nd & Buchowski MS (2014). The relationship of oxidative stress, adiposity and metabolic risk factors in healthy Black and White American youth. Pediatric obesity 9, 43–52.
251. Watson GS, Peskind ER, Asthana S, Purganan K, Wait C, Chapman D, Schwartz MW, Plymate S & Craft S (2003). Insulin increases CSF Aβ42 levels in normal older adults. Neurology 60, 1899–1903.
252. Wehrli FW, Hopkins JA, Hwang SN, Song HK, Snyder PJ & Haddad JG (2000). Cross-sectional study of osteopenia with quantitative MR imaging and bone densitometry. Radiology 217, 527–538.
253. Weinstein G, Beiser AS, Choi SH, Preis SR, Chen TC, Vorgas D, Au R, Pikula A, Wolf PA, DeStefano AL, Vasan RS & Seshadri S (2014). Serum brain-derived neurotrophic factor and the risk for dementia: the Framingham Heart Study. JAMA Neurol 71, 55–61.
254. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL & Ferrante AW Jr (2003). Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112, 1796–1808.
255. Whitmer RA, Gunderson EP, Barrett-Connor E, Quesenberry CP Jr & Yaffe K (2005a). Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study. BMJ 330, 1360.
256. Whitmer RA, Gunderson EP, Quesenberry CP Jr, Zhou J & Yaffe K (2007). Body mass index in midlife and risk of Alzheimer disease and vascular dementia. Curr Alzheimer Res 4, 103–109.
257. Whitmer RA, Gustafson DR, Barrett-Connor E, Haan MN, Gunderson EP & Yaffe K (2008). Central obesity and increased risk of dementia more than three decades later. Neurology 71, 1057–1064.
258. Whitmer RA, Sidney S, Selby J, Johnston SC & Yaffe K (2005b). Midlife cardiovascular risk factors and risk of dementia in late life. Neurology 64, 277–281.
259. Wildman RP, Muntner P, Reynolds K, McGinn AP, Rajpathak S, Wylie-Rosett J & Sowers MR (2008). The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999–2004). Arch Intern Med 168, 1617–1624.
260. Williamson DF, Pamuk E, Thun M, Flanders D, Byers T & Heath C (1995). Prospective study of intentional weight loss and mortality in never-smoking overweight US white women aged 40–64 years. Am J Epidemiol 141, 1128–1141.
261. Williamson DF, Pamuk E, Thun M, Flanders D, Byers T & Heath C (1999). Prospective study of intentional weight loss and mortality in overweight white men aged 40–64 years. Am J Epidemiol 149, 491–503.
262. Wolffe AP & Guschin D (2000). Review: chromatin structural features and targets that regulate transcription. J Struct Biol 129, 102–122.
263. Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA & Chen H (2003). Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112, 1821–1830.
264. Yaffe K, Lindquist K, Penninx BW, Simonsick EM, Pahor M, Kritchevsky S, Launer L, Kuller L, Rubin S & Harris T (2003). Inflammatory markers and cognition in well-functioning African-American and white elders. Neurology 61, 76–80.
265. Yamada K, Mizuno M & Nabeshima T (2002). Role for brain-derived neurotrophic factor in learning and memory. Life Sci 70, 735–744.
266. Yang H & Li X (2012). The role of fatty acid metabolism and lipotoxicity in pancreatic β-cell injury: Identification of potential therapeutic targets. Acta Pharm Sin B 2, 396–402.
267. Yoshizaki T, Milne JC, Imamura T, Schenk S, Sonoda N, Babendure JL, Lu JC, Smith JJ, Jirousek MR & Olefsky JM (2009). SIRT1 exerts anti-inflammatory effects and improves insulin sensitivity in adipocytes. Mol Cell Biol 29, 1363–1374.
268. Zalesin KC, Franklin BA, Miller WM, Peterson ED & McCullough PA (2011). Impact of obesity on cardiovascular disease. Med Clin North Am 95, 919–937.
269. Zhang X & Lerman LO (2015). Obesity and renovascular disease. Am J Physiol Renal Physiol 309, F273–F279.
270. Zhao L & Ackerman SL (2006). Endoplasmic reticulum stress in health and disease. Curr Opin Cell Biol 18, 444–452.
271. Zhou XJ, Rakheja D, Yu X, Saxena R, Vaziri ND & Silva FG (2008). The aging kidney. Kidney Int 74, 710–720.